← Back to Search

CEUS/aMRI for Hepatocellular Carcinoma

N/A
Recruiting
Research Sponsored by University of Texas Southwestern Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 years
Awards & highlights

Study Summary

The study will be conducted at the following locations: UT Southwestern Medical Center Parkland Health and Hospital System University of Michigan Investigators will prospectively compare the performance of dynamic contrast enhanced abbreviated MRI (AMRI) and contrast-enhanced ultrasound for early-stage HCC detection in patients with indeterminate liver nodules.

Eligible Conditions
  • Hepatocellular Carcinoma
  • Liver Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Early HCC Detection
HCC Detection

Trial Design

1Treatment groups
Experimental Treatment
Group I: CEUS/aMRIExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor
1,047 Previous Clinical Trials
1,053,199 Total Patients Enrolled
8 Trials studying Hepatocellular Carcinoma
375 Patients Enrolled for Hepatocellular Carcinoma
University of MichiganOTHER
1,795 Previous Clinical Trials
6,373,336 Total Patients Enrolled
1 Trials studying Hepatocellular Carcinoma
317 Patients Enrolled for Hepatocellular Carcinoma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
Amit Singal 2023. "CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06184152.
All > Dallas > Fort Worth
~400 spots leftby Nov 2028
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top